These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 19483704)
21. Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 Projections. Lindsley CW ACS Chem Neurosci; 2019 Mar; 10(3):1115. PubMed ID: 30889957 [No Abstract] [Full Text] [Related]
22. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555 [No Abstract] [Full Text] [Related]
23. Maximizing exclusivity for drug products. French H Nat Rev Drug Discov; 2005 Sep; 4(9):709. PubMed ID: 16178117 [No Abstract] [Full Text] [Related]
24. Patent watch. Harrison C Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462 [No Abstract] [Full Text] [Related]
32. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
33. Drug patent plan gets mixed reviews. Butler D Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077 [No Abstract] [Full Text] [Related]
34. No money, no meds. Mabry M Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
35. Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues. Schuklenk U Monash Bioeth Rev; 2003 Apr; 22(2):63-8. PubMed ID: 15069958 [No Abstract] [Full Text] [Related]
36. India remains on US trade "priority watch list" for failing to uphold international drug company patents. Arie S BMJ; 2013 May; 346():f2949. PubMed ID: 23657189 [No Abstract] [Full Text] [Related]
37. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals. Correa CM Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300 [No Abstract] [Full Text] [Related]
38. Out-licensing: a practical approach for improvement of access to medicines in poor countries. Friedman MA; den Besten H; Attaran A Lancet; 2003 Jan; 361(9354):341-4. PubMed ID: 12559883 [No Abstract] [Full Text] [Related]
39. A day late and a few million dollars short. Goldenson D Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055 [TBL] [Abstract][Full Text] [Related]